Polysomnographic features in infants with early diagnosis of congenital hypothyroidism

G Terán-Pérez1, Y Arana-Lechuga, R O González-Robles

  • 1Sleep Disorders Clinic, Universidad Autónoma Metropolitana-Iztapalapa, CP 09340, Mexico City, Mexico.

Brain & Development
|August 12, 2009
PubMed

Insights

Congenital hypothyroidism in infants is linked to increased central sleep apnea and altered sleep patterns. Early thyroid hormone replacement therapy may help reduce these respiratory issues and normalize sleep organization.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Pediatrics

Background:

  • Thyroid hormones are crucial for brain development.
  • Congenital hypothyroidism (CH) is detected via newborn screening.
  • The effect of early CH on infant sleep patterns remains unclear.

Purpose of the Study:

  • To investigate polysomnographic sleep features in infants with CH.
  • To determine the impact of early thyroid hormone deficiency on sleep organization.
  • To assess the relationship between CH, sleep disturbances, and brain maturation.

Main Methods:

  • Polysomnography was performed on infants (1.5-18 months) with CH.
  • Infants received immediate thyroid hormone replacement therapy.
  • Sleep recordings analyzed central apnea, hypopnea, sleep stages (indeterminate, quiet, REM).

Main Results:

  • 43% of infants with CH exhibited central apnea; 83% had hypopnea.
  • Central apnea prevalence decreased with age; indeterminate sleep increased, quiet sleep decreased.
  • REM sleep correlated with earlier treatment initiation and younger age at study.

Conclusions:

  • CH is associated with a high prevalence of central sleep apnea in infants.
  • Sleep-related respiratory alterations in CH may be linked to impaired brain maturation.
  • Thyroid hormone replacement therapy appears to reduce sleep respiratory disturbances.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...